Galera Therapeutics, Inc. Contracts & Agreements
36 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (3)
- Human Resources (20)
- Uncategorized (2)
- Separation Agreement and General Release by Mark Bachleda, dated August 16, 2023 (Filed With SEC on November 14, 2023)
- Form of Securities Purchase Agreement dated February 15, 2023 by and among the Company and the purchasers named therein (Filed With SEC on February 16, 2023)
- Placement Agency Agreement dated February 15, 2023, by and between the Company and Piper Sandler & Co (Filed With SEC on February 16, 2023)
- Form of Warrant (Filed With SEC on February 16, 2023)
- Employment Agreement, dated July 25,2022, by and between Galera Therapeutics, Inc. and Eugene Kennedy (Filed With SEC on November 9, 2022)
- Employment Agreement, dated October 7, 2021, by and between Galera Therapeutics, Inc. and Mark Bachleda and amendments to Employment Agreement, dated January 31, 2022 and... (Filed With SEC on November 9, 2022)
- Galera Therapeutics, Inc. Non-Employee Director Compensation Program (effective as of February 11, 2021 and amended may 5, 2022) (Filed With SEC on August 9, 2022)
- Employment Agreement, dated October 7, 2021, by and between Galera Therapeutics, Inc. and Mark Bachleda and amendment to Employment Agreement, dated January 31, 2022, by and... (Filed With SEC on March 10, 2022)
- Employment Agreement, dated October 7, 2021, by and between Galera Therapeutics, Inc. and Mark Bachleda (Filed With SEC on November 10, 2021)
- Employment Agreement, dated October 7, 2021, by and between Galera Therapeutics, Inc. and Jennifer Evans Stacey (Filed With SEC on November 10, 2021)
- Master Manufacturing Services Agreement between Patheon Manufacturing Services LLC and Galera Therapeutics, Inc., dated August 13, 2021 (Filed With SEC on August 18, 2021)
- Galera Therapeutics, Inc. Non-Employee Director Compensation Program (effective as of February 11, 2021) (Filed With SEC on March 11, 2021)
- Description of Securities (Filed With SEC on March 11, 2021)
- Warrant Purchase Agreement, dated May 11, 2020, by and between Galera Therapeutics, Inc. and Clarus IV Galera Royalty AIV, L.P (Filed With SEC on August 10, 2020)
- Amendment No. 1 to Amended and Restated Purchase and Sale Agreement, dated May 11, 2020, by and between Galera Therapeutics, Inc. and Clarus IV Galera Royalty AIV, L.P (Filed With SEC on August 10, 2020)
- Form of Warrant to Purchase Stock, dated May 11, 2020, issued by Galera Therapeutics, Inc. to Clarus IV Galera Royalty AIV, L.P., together with a schedule of warrantholders (Filed With SEC on August 10, 2020)
- Description of Securities (Filed With SEC on March 10, 2020)
- Galera Therapeutics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 10, 2020)
- Galera Therapeutics, Inc. 2019 Incentive Award Plan (Filed With SEC on October 28, 2019)
- Form of Certificate of Common Stock (Filed With SEC on October 28, 2019)
- Second Amended and Restated Investors Rights Agreement, dated as of August 30, 2018, by and among Galera Therapeutics, Inc. and the investors party thereto (Filed With SEC on October 28, 2019)
- Employment Agreement, dated October 25, 2019, by and between Galera Therapeutics, Inc. and J. Mel Sorensen, M.D (Filed With SEC on October 28, 2019)
- Employment Agreement, dated October 25, 2019, by and between Galera Therapeutics, Inc. and Robert A. Beardsley, Ph.D (Filed With SEC on October 28, 2019)
- Employment Agreement, dated October 25, 2019 by and between Galera Therapeutics, Inc. and Christopher Degnan (Filed With SEC on October 28, 2019)
- Employment Agreement, dated October 25, 2019, by and between Galera Therapeutics, Inc. and Jon T. Holmlund, M.D (Filed With SEC on October 28, 2019)
- Employment Agreement, dated October 25, 2019, by and between Galera Therapeutics, Inc. and Arthur J. Fratamico, R.Ph (Filed With SEC on October 28, 2019)
- Form of Indemnification Agreement between Galera Therapeutics, Inc. and its directors and officers (Filed With SEC on October 28, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 28, 2019)
- Form of Stock Option Award Agreement under the Galera Therapeutics, Inc. 2019 Incentive Award Plan (Filed With SEC on October 28, 2019)
- Form of Restricted Stock Award Agreement under the Galera Therapeutics, Inc. 2019 Incentive Award Plan (Filed With SEC on October 28, 2019)
- Form of Restricted Stock Unit Award Agreement under the Galera Therapeutics, Inc. 2019 Incentive Award Plan (Filed With SEC on October 28, 2019)
- Galera Therapeutics, Inc. Non-Employee Director Compensation Policy (Filed With SEC on October 28, 2019)
- Galera Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on October 28, 2019)
- Second Amended and Restated Investors Rights Agreement, dated as of August 30, 2018, by and among Galera Therapeutics, Inc. and the investors party thereto (Filed With SEC on October 11, 2019)
- Amended and Restated Purchase and Sale Agreement, dated as of November 14, 2018, by and among Galera Therapeutics, Inc. and Clarus IV Galera Royalty AIV, L.P., Clarus IV-A, L.P.,... (Filed With SEC on October 11, 2019)
- Galera Therapeutics, Inc. Equity Incentive Plan, as amended (Filed With SEC on October 11, 2019)